Cargando…

Rifampin-Associated Renal Failure

Rifampin is an effective and widely used for the treatment of both active and latent tuberculosis. Although significant side effects are rare, severe side effects such as acute renal failure have been reported in the literature, usually secondary to acute interstitial nephritis. We report a case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Kathleen, Rennke, Helmut, Richardson, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617427/
https://www.ncbi.nlm.nih.gov/pubmed/37908633
http://dx.doi.org/10.7326/aimcc.2022.1200
_version_ 1785129600936837120
author Miller, Kathleen
Rennke, Helmut
Richardson, Eugene
author_facet Miller, Kathleen
Rennke, Helmut
Richardson, Eugene
author_sort Miller, Kathleen
collection PubMed
description Rifampin is an effective and widely used for the treatment of both active and latent tuberculosis. Although significant side effects are rare, severe side effects such as acute renal failure have been reported in the literature, usually secondary to acute interstitial nephritis. We report a case of rifampin-induced acute renal failure due to heme pigment–related injury in a patient who was receiving daily rifampin as therapy for latent tuberculosis. The patient case illustrates considering rifampin as a potential cause of acute renal failure when no other cause is identified.
format Online
Article
Text
id pubmed-10617427
institution National Center for Biotechnology Information
language English
publishDate 2023
record_format MEDLINE/PubMed
spelling pubmed-106174272023-10-31 Rifampin-Associated Renal Failure Miller, Kathleen Rennke, Helmut Richardson, Eugene Ann Intern Med Clin Cases Article Rifampin is an effective and widely used for the treatment of both active and latent tuberculosis. Although significant side effects are rare, severe side effects such as acute renal failure have been reported in the literature, usually secondary to acute interstitial nephritis. We report a case of rifampin-induced acute renal failure due to heme pigment–related injury in a patient who was receiving daily rifampin as therapy for latent tuberculosis. The patient case illustrates considering rifampin as a potential cause of acute renal failure when no other cause is identified. 2023-04 2023-04-18 /pmc/articles/PMC10617427/ /pubmed/37908633 http://dx.doi.org/10.7326/aimcc.2022.1200 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access: This is an open access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND), which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. See: https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Article
Miller, Kathleen
Rennke, Helmut
Richardson, Eugene
Rifampin-Associated Renal Failure
title Rifampin-Associated Renal Failure
title_full Rifampin-Associated Renal Failure
title_fullStr Rifampin-Associated Renal Failure
title_full_unstemmed Rifampin-Associated Renal Failure
title_short Rifampin-Associated Renal Failure
title_sort rifampin-associated renal failure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617427/
https://www.ncbi.nlm.nih.gov/pubmed/37908633
http://dx.doi.org/10.7326/aimcc.2022.1200
work_keys_str_mv AT millerkathleen rifampinassociatedrenalfailure
AT rennkehelmut rifampinassociatedrenalfailure
AT richardsoneugene rifampinassociatedrenalfailure